Consumer groups, labor unions, and Senator Elizabeth Warren have urged the FTC to block Novo Holdings from acquiring Catalent. Concerns center on competition in weight loss drugs and gene therapies.
Shares of Catalent, Inc. (NYSE:CTLT – Get Free Report) have received an average recommendation of “Hold” from the eight ratings firms that are covering the company, Marketbeat Ratings reports. Eight ...